Second generation GKA therapy (Hualing Pharmaceutical)

第二代GKA（华领医药）

Report date: 2024/09/14 10:21:24
NMEFirst In Class

Base Information

Drug NameSecond generation GKA therapy (Hualing Pharmaceutical)
Drug Alias Name2nd Generation GKA therapy (Hualing Pharmaceutical)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlucokinase activators
TargetsGlucokinase
Therapy Area/IndicationsDiabetes Mellitus, Type 2Metabolic Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusIND
Highest Status in ChinaPreclinical
Originator CompaniesHualing Pharmaceutical Technology (Shanghai) Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesHualing Pharmaceutical Technology (Shanghai) Co Ltd
Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus, Type 2Metabolic Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A